Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
D000721:Ancrod / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001809:Blood Viscosity; D002908:Chronic Disease; D004906:Erythrocyte Count; D005340:Fibrinogen; D006801:Humans; D007383:Intermittent Claudication / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007511:Ischemia / Q000097:blood / Q000188:drug therapy*; D050356:Lipid Metabolism; D009203:Myocardial Infarction / Q000150:complications; D010951:Plasma Exchange; D012212:Rheology; D014652:Vascular Diseases / Q000097:blood / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D005340:Fibrinogen; D000721:Ancrod; D001241:Aspirin